Literature DB >> 8200394

Non-matched images with 123I-IMP and 99mTc-bicisate single-photon emission tomography in the demonstration of focal hyperaemia during the subacute phase of an ischaemic stroke.

F Tamgac1, J L Moretti, G Defer, P Weinmann, A Roussi, P Cesaro.   

Abstract

Focal hyperaemia is a fairly common phenomenon in the subacute phase of an ischaemic stroke. This has rarely been reported with iodine-123 iodoamphetamine (IMP) and has never been identified using technetium-99m bicisate (99mTc-ECD). In this report, we present the case of a patient suffering from a left cerebral posterior stroke. 123I-IMP single-photon emission tomography (SPET) images showed a large area of significantly increased IMP activity located in the left occipital region whereas 99mTc-bicisate SPET displayed hypoactivity in the same area.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8200394     DOI： 10.1007/bf00188674

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  17 in total

1.  Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO.

Authors:  S Nakano; K Kinoshita; S Jinnouchi; H Hoshi; K Watanabe
Journal:  J Nucl Med       Date:  1989-02       Impact factor: 10.057

2.  The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain.

Authors:  N A Lassen
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

3.  Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.

Authors:  J Léveillé; G Demonceau; R C Walovitch
Journal:  J Nucl Med       Date:  1992-04       Impact factor: 10.057

4.  Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans.

Authors:  J Léveillé; G Demonceau; M De Roo; P Rigo; R Taillefer; R A Morgan; D Kupranick; R C Walovitch
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

5.  Focal cerebral hyperemia in acute stroke. Incidence, pathophysiology and clinical significance.

Authors:  T S Olsen; B Larsen; E B Skriver; M Herning; E Enevoldsen; N A Lassen
Journal:  Stroke       Date:  1981 Sep-Oct       Impact factor: 7.914

6.  Amines for brain tomoscintigraphy.

Authors:  J L Moretti; L Cinotti; P Cesaro; G Defer; Y Joulin; A Sergent; N Vigneron; J R Rapin; C Raynaud
Journal:  Nucl Med Commun       Date:  1987-07       Impact factor: 1.690

7.  Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine.

Authors:  H Creutzig; O Schober; P Gielow; R Friedrich; H Becker; H Dietz; H Hundeshagen
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

8.  Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.

Authors:  S Vallabhajosula; R E Zimmerman; M Picard; P Stritzke; I Mena; R S Hellman; R S Tikofsky; M G Stabin; R A Morgan; S J Goldsmith
Journal:  J Nucl Med       Date:  1989-05       Impact factor: 10.057

9.  "Luxury perfusion" with 99mTc-HMPAO and 123I-IMP SPECT imaging during the subacute phase of stroke.

Authors:  J L Moretti; G Defer; L Cinotti; P Cesaro; J D Degos; N Vigneron; D Ducassou; B L Holman
Journal:  Eur J Nucl Med       Date:  1990

10.  Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. I: Goals, objectives, and data collection procedures.

Authors:  F M Yatsu; C Becker; K R McLeroy; B Coull; J Feibel; G Howard; J F Toole; M D Walker
Journal:  Stroke       Date:  1986 Mar-Apr       Impact factor: 7.914
View more
  2 in total

1.  A case of intravascular lymphoma with increased regional cerebral blood flow in I-123 IMP single-photon emission CT.

Authors:  Chihoko Miyazaki; Masaya Mukai; Yuriko Kawaai; Miki Takeda; Norio Katoh; Syunsuke Nagano; Kozoh Kubo; Michifumi Kohno
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

2.  Does technetium-99m bicisate image local brain metabolism in late ictal temporal lobe epilepsy?

Authors:  J T Kuikka; E Mervaala; E Vanninen; R Kälviäinen
Journal:  Eur J Nucl Med       Date:  1994-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.